AgeneBio is a pharmaceutical company dedicated to developing therapeutics that prevent neurodegeneration, preserve and restore cognitive brain function. It helps unserved patients battling amnestic mild cognitive impairment (aMCI), the symptomatic pre-dementia stage of Alzheimer’s disease, and other neurological and psychiatric diseases.